Holds 3 active US DMFs for dextroamphetamine, filing since 2016. Its 2025 FDA inspection closed as NAI.
Holds 3 active US DMFs for dextroamphetamine, filing since 2016. Its 2025 FDA inspection closed as NAI.
Holds 5 active US DMFs for dextroamphetamine, filing since 2001. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds 3 active US DMFs for dextroamphetamine, filing since 2017. Its 2022 FDA inspection closed as NAI.
Holds 2 active US DMFs for dextroamphetamine, filing since 2001. Its 2025 FDA inspection closed as VAI.
Holds 4 active US DMFs for dextroamphetamine, filing since 2000.
Holds 3 active US DMFs for dextroamphetamine, filing since 2002. Its 2026 FDA inspection closed as OAI.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
Open the full list with a free accountThe order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for freeFixed-dose combinations containing dextroamphetamine. Each page leads with the verified API makers of every component.